Robot-assisted upper urinary tract repair surgery using the MP1000 system: a prospective, single-center, single-arm clinical study.

IF 1.7 3区医学 Q4 ANDROLOGY

Translational andrology and urology Pub Date : 2025-06-30 Epub Date: 2025-06-26 DOI:10.21037/tau-2025-228

Bing Wang, Wenzhi Gao, Kunlin Yang, Yaming Gu, Zhihua Li, Xinfei Li, Zihui Gao, Zheng Zhang, Xuesong Li

{"title":"Robot-assisted upper urinary tract repair surgery using the MP1000 system: a prospective, single-center, single-arm clinical study.","authors":"Bing Wang, Wenzhi Gao, Kunlin Yang, Yaming Gu, Zhihua Li, Xinfei Li, Zihui Gao, Zheng Zhang, Xuesong Li","doi":"10.21037/tau-2025-228","DOIUrl":null,"url":null,"abstract":"Background: The MP1000 system is a newly developed surgical robot in China. This study, based on our single-center experience, evaluates its feasibility, safety, and effectiveness in upper urological repair surgeries.Methods: This prospective, single-center, single-arm clinical study was conducted from June 2023 to December 2023. One surgeon performed 20 upper urinary tract repair operations using the MP1000 system. Prospective demographic data and perioperative outcomes were collected, and postoperative complications and success rates were analyzed. The ergonomics were evaluated using national aeronautics and space administration task load index (NASA-TLX).Results: All cases were successfully completed without the need to switch to standard laparoscopic or open surgery. The average docking time was 4.1 [interquartile range (IQR), 3-5] min, the average control time was 145.1 (IQR, 102-195) min, and the average operation time was 189.1 (IQR, 145-248) min. The average estimated blood loss (EBL) was 58.5 (IQR, 20-100) mL. The mean length of stay was 6.95 (IQR, 4-8) days. All patients had no postoperative lumbago symptoms and no Clavien-Dindo grade III or higher-grade complications. The estimated glomerular filtration rate (eGFR) was 99.29 (IQR, 95.39-126.14) mL/min/1.73 m2 on the first day after surgery, 101.13 (IQR, 89.73-124.7) mL/min/1.73 m2 on the third day after surgery, and 78.38 (IQR, 57.12-91.84) mL/min/1.73 m2 on the third months after surgery. The short-term success rate was 100%. The overall score of NASA-TLX is 6.70±4.81.Conclusions: The MP1000 system is safe and effective for a variety of upper urinary tract repair procedures.","PeriodicalId":23270,"journal":{"name":"Translational andrology and urology","volume":"14 6","pages":"1723-1733"},"PeriodicalIF":1.7000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12271945/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational andrology and urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/tau-2025-228","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/26 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ANDROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The MP1000 system is a newly developed surgical robot in China. This study, based on our single-center experience, evaluates its feasibility, safety, and effectiveness in upper urological repair surgeries.

Methods: This prospective, single-center, single-arm clinical study was conducted from June 2023 to December 2023. One surgeon performed 20 upper urinary tract repair operations using the MP1000 system. Prospective demographic data and perioperative outcomes were collected, and postoperative complications and success rates were analyzed. The ergonomics were evaluated using national aeronautics and space administration task load index (NASA-TLX).

Results: All cases were successfully completed without the need to switch to standard laparoscopic or open surgery. The average docking time was 4.1 [interquartile range (IQR), 3-5] min, the average control time was 145.1 (IQR, 102-195) min, and the average operation time was 189.1 (IQR, 145-248) min. The average estimated blood loss (EBL) was 58.5 (IQR, 20-100) mL. The mean length of stay was 6.95 (IQR, 4-8) days. All patients had no postoperative lumbago symptoms and no Clavien-Dindo grade III or higher-grade complications. The estimated glomerular filtration rate (eGFR) was 99.29 (IQR, 95.39-126.14) mL/min/1.73 m² on the first day after surgery, 101.13 (IQR, 89.73-124.7) mL/min/1.73 m² on the third day after surgery, and 78.38 (IQR, 57.12-91.84) mL/min/1.73 m² on the third months after surgery. The short-term success rate was 100%. The overall score of NASA-TLX is 6.70±4.81.

Conclusions: The MP1000 system is safe and effective for a variety of upper urinary tract repair procedures.

查看原文本刊更多论文

使用MP1000系统的机器人辅助上尿路修复手术：一项前瞻性、单中心、单臂临床研究

背景：MP1000系统是国内最新开发的手术机器人。本研究基于我们的单中心经验，评估其在上泌尿外科修复手术中的可行性、安全性和有效性。方法：这项前瞻性、单中心、单臂临床研究于2023年6月至2023年12月进行。一名外科医生使用MP1000系统进行了20例上尿路修复手术。收集前瞻性人口统计学资料和围手术期结果，分析术后并发症和成功率。采用美国国家航空航天局任务负荷指数（NASA-TLX）对其进行了人机工程评价。结果：所有病例均成功完成，无需切换到标准腹腔镜或开放手术。平均停靠时间4.1[四分位间距（IQR）， 3-5] min，平均对照时间145.1 (IQR, 102-195) min，平均手术时间189.1 (IQR, 145-248) min。平均估计失血量（EBL） 58.5 (IQR, 20-100) mL，平均住院时间6.95 (IQR, 4-8) d。所有患者均无术后腰痛症状，无Clavien-Dindo III级或更高级别并发症。术后第1天肾小球滤过率（eGFR）为99.29 (IQR, 95.39 ~ 126.14) mL/min/1.73 m2，术后第3天为101.13 (IQR, 89.73 ~ 124.7) mL/min/1.73 m2，术后第3个月为78.38 (IQR, 57.12 ~ 91.84) mL/min/1.73 m2。短期成功率为100%。NASA-TLX总分为6.70±4.81。结论：MP1000系统在各种上尿路修复手术中是安全有效的。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Translational andrology and urology Medicine-Urology

CiteScore

4.10

自引率

5.00%

发文量

期刊介绍： ranslational Andrology and Urology (Print ISSN 2223-4683; Online ISSN 2223-4691; Transl Androl Urol; TAU) is an open access, peer-reviewed, bi-monthly journal (quarterly published from Mar.2012 - Dec. 2014). The main focus of the journal is to describe new findings in the field of translational research of Andrology and Urology, provides current and practical information on basic research and clinical investigations of Andrology and Urology. Specific areas of interest include, but not limited to, molecular study, pathology, biology and technical advances related to andrology and urology. Topics cover range from evaluation, prevention, diagnosis, therapy, prognosis, rehabilitation and future challenges to urology and andrology. Contributions pertinent to urology and andrology are also included from related fields such as public health, basic sciences, education, sociology, and nursing.